Dosing regimen

Patent Number: CN-117979986-A

Publication Year: 2024

Application Year: 2022

Priority Year: 2021

Jurisdictions: CN

Status: Pending

Inventors:

AGSNAP MIKKEL ASKJAER

Applicants:

  1. Zealand Pharma (Denmark)
    2. [NORA names: Zealand Pharma; Private Research; Denmark; Europe, EU; Nordic; OECD]

Abstract

The present invention relates to dosing regimens of compounds having agonist activity to GLP-1 (glucagon-like peptide 1) and GLP-2 (glucagon-like peptide 2) receptors for the treatment of obesity and related disorders.

Patent Family Records (1)

Dosing regimen

Zealand Pharma (Denmark), Zealand Pharma AS AGSNAP MIKKEL ASKJAER

2024, CN-117979986-A

Data Provider: Digital Science

LINKS
+

External Systems

SUBJECTS
+

PATENT CATEGORIES
+

IPCR Classification

CPC Classification

[No Data Available]

METRICS
+

Citation Metrics

Times Cited in Patents: 0external link

References to Patents: [No Data Available]

References to Publications: 0external link